These findings, combined with the aforementioned metabolic alterations, demonstrated that S100A10 induced glycolysis by activating the Src/ANXA2/AKT/mTOR signaling pathway, leading to aerobic glycolysis, apoptotic resistance, and rapid proliferation of GC cells. Here, S100A10 is linked to gastric cancer.